[1] Guariguata L, Whiting DR, Hambleton I, et al. Global estimates of diabetes prevalence for 2013 and projections for 2035[J]. Diabetes Res Clin Pract, 2014, 103(2):137-149.
[2] Maiese K. Programming apoptosis and autophagy with novel approaches for diabetes mellitus[J]. Curr Neurovasc Res, 2015, 12(2):173-188.
[3] Cogger K, Nostro MC. Recent advances in cell replacement therapies for the treatment of type 1 diabetes[J]. Endocrinology, 2015, 156(1):8-15.
[4] Tang DQ, Cao LZ, Burkhardt BR, et al. In vivo and in vitro characterization of insulin-producing cells obtained from murine bone marrow[J]. Diabetes, 2004, 53(7):1721-1732.
[5] Davey GC, Patil SB, O'Loughlin A, et al. Mesenchymal stem cell-based treatment for microvascular and secondary complications of diabetes mellitus[J]. Front Endocrinol (Lausanne), 2014, 5(86):95-100.
[6] Heo JS, Choi Y, Kim HS, et al. Comparison of molecular profiles of human mesenchymal stem cells derived from bone marrow, umbilical cord blood, placenta and adipose tissue[J]. Int J Mol Med, 2016, 37(1):115-125.
[7] Rekittke NE, Ang M, Rawat D, et al. Regenerative therapy of type 1 diabetes mellitus:From pancreatic islet transplantation to mesenchymal stem cells[J]. Stem Cells Int, 2016, 2016(3764681).
[8] Montanucci P, Alunno A, Basta G, et al. Restoration of t cell substes of patients with type 1 diabetes mellitus by microencapsulated human umbilical cord Wharton jelly-derived mesenchymal stem cells:An in vitro study[J]. Clin Immunol, 2016, 163:34-41.
[9] 柴树宏, 鲍艳春. 人脐带间充质干细胞与骨髓间充质干细胞分化为胰岛素分泌细胞的能力比较[J]. 实用医学杂志, 2014,30(1):52-54.
[10] Nakao N, Nakayama T, Yahata T, et al. Adipose tissue-derived mesenchymal stem cells facilitate hematopoiesis in vitro and in vivo:advantages over bone marrow-derived mesenchymal stem cells[J]. Am J Pathol, 2010, 177(2):547-554.
[11] Paek HJ, Kim C, Williams SK. Adipose stem cell-based regenerative medicine for reversal of diabetic hyperglycemia[J]. World J Diabetes, 2014, 5(3):235-243.
[12] 梁梦璐, 胡永华. 1型糖尿病病因流行病学研究进展[J]. 中华疾病控制杂志, 2013, 17(4):349-353.
[13] 彭聪. 2型糖尿病住院患者血糖控制现状及慢性并发症的流行病学调查[J]. 中国卫生检验杂志, 2014, 24(21):3153-3155.
[14] 杨艳辉, 陈莉明. 间充质干细胞治疗糖尿病微血管并发症研究进展[J]. 中国慢性病预防与控制, 2015, 23(9):702-705.
[15] Mathews V, Hanson PT, Ford E, et al. Recruitment of bone marrow-derived endothelial cells to sites of pancreatic beta-cell injury[J]. Diabetes, 2004, 53(1):91-98.
[16] 李丽. 影响糖尿病视网膜病变相关因素临床研究[J]. 中国实用医药, 2013,8(24):110-111.
[17] 张晓阳. 糖尿病视网膜病变的中西医治疗[J]. 中国临床医生, 2011, 39(11):22-24.
[18] 蹇文渊, 段俊国. 糖尿病视网膜病变的中西医治疗现状[J]. 中医眼耳鼻喉杂志, 2013, 3(2):93-96.
[19] 周金文, 利焕廉, 左炜. 间充质干细胞对糖尿病病变模型大鼠血视网膜屏障的影响研究[J]. 亚太传统医药, 2014, 10(23):10-12.
[20] Tziomalos K, Athyros VG. Diabetic nephropathy:New risk factors and improvements in diagnosis[J]. Rev Diabet Stud, 2015, 12(1/2):110-118.
[21] 范文君, 祝菁菁, 黄韻宇,等. 我国糖尿病肾病的流行现状及其危险因素[J]. 中国慢性病预防与控制, 2013, 21(6):748-751.
[22] Qian Y, Feldman E, Pennathur S, et al. From fibrosis to sclerosis:mechanisms of glomerulosclerosis in diabetic nephropathy[J]. Diabetes, 2008, 57(6):1439-1445.
[23] Morigi M, Rota C, Remuzzi G. Mesenchymal stem cells in kidney repair[J]. Methods Mol Biol, 2016, 1416:89-107.
[24] Griffin TP, Martin WP, Islam N, et al. The promise of mesenchymal stem cell therapy for diabetic kidney disease[J]. Curr Diab Rep, 2016, 16(5):42.
[25] 蚁淳, 陈佩仪, 陈琳莹. 糖尿病周围神经病变诊断、治疗和护理的研究进展[J]. 现代中西医结合杂志, 2014, 23(12):1363-1366.
[26] 赵岐, 李晶玉, 王红艳. 糖尿病患者周围神经病变的特点及危险因素分析[J]. 中国民康医学, 2010, 22(24):3107-3108.
[27] 郑培, 安沂华, 王晓东,等. 脐带间充质干细胞移植治疗糖尿病周围神经病变的疗效观察[J]. 武警医学, 2013, 24(5):398-401.
[28] 许樟荣. 糖尿病足病的诊治与预防[J]. 中华损伤与修复杂志:电子版, 2014, 9(2):118-122.
[29] 高赟, 冉兴无. 糖尿病足病治疗进展[J]. 实用医院临床杂志, 2014, 11(1):10-13.
[30] Qin HL, Zhu XH, Zhang B, et al. Clinical evaluation of human umbilical cord mesenchymal stem cell transplantation after angioplasty for diabetic foot[J]. Exp Clin Endocrinol Diabetes, 2016, 124(8):497-503.
[31] 陈高扬, 常非, 李锐,等. 不同来源干细胞治疗糖尿病性足病的原理与效果比较[J]. 中国组织工程研究, 2015, 19(41):6718-6724.
[32] 郑锡锋, 吴铿. 糖尿病心肌病临床诊治进展[J]. 中国医学创新, 2014, 11(14):149-152.
[33] 赵娜娜. 糖尿病心肌病的治疗进展[J]. 医学综述, 2013, 19(3):502-504.
[34] Volarevic V, Arsenijevic N, Lukic ML, et al. Concise review:Mesenchymal stem cell treatment of the complications of diabetes mellitus[J]. Stem Cells, 2011, 29(1):5-10.
[35] 郭明,王镁,于世家,等.5种检查方法在糖尿病周围神经病变诊断中的效能评估[J]. 西安交通大学学报:医学版,2015,36(4):568-570. |